.
.
.
.

Coronavirus: Saudi Arabia reports 104 new COVID-19 cases over the past 24 hours

Published: Updated:

Saudi Arabia has reported 104 new coronavirus cases over the past 24 hours, after two consecutive days of less than 100 new infections, according to the Ministry of Health.

For more coronavirus news, visit our dedicated page.

The total number of confirmed cases increased to 363,259. However, only 2,239 active cases remain in the Kingdom.

Of the new cases, 47 were detected in the city of Riyadh, 24 in Mecca and four in Medina, according to the ministry.

For all the latest headlines follow our Google News channel online or via the app


The total number of recoveries reached 354,755 after an additional 146 individuals recovered.

Meanwhile, nine people died due to COVID-19 complications over the past 24 hours, raising the death toll to 6,265.



Saudi Arabia launched its COVID-19 vaccine campaign in December with over 700,000 people signing up since registration opened on December 15.
The Ministry of Health has confirmed the safety and efficacy of the vaccine, after successful tests showed it provided a strong immune response and antibodies in trial participants, according to SPA.

The Saudi Minister of Health announces that the coronavirus vaccine has arrived in the Kingdom at the 2021 Saudi Budget Forum. (Via @SaudiMOH Twitter)
The Saudi Minister of Health announces that the coronavirus vaccine has arrived in the Kingdom at the 2021 Saudi Budget Forum. (Via @SaudiMOH Twitter)



Health Minister Tawfiq al-Rabiah told Al Arabiya last week that vaccines are set to reach all the regions of Saudi Arabia within three weeks.

Saudi Arabia is set to receive three million doses of the Pfizer COVID-19 vaccine by the end of May 2021, according to Al Arabiya’s correspondent in Riyadh.

Read more:

Coronavirus: China’s CNBG has supplied three million COVID-19 vaccine doses to UAE

Coronavirus: Indian vaccine makers end disagreement, guarantee ‘smooth rollout’

Coronavirus: Putin, Merkel discuss possible joint COVID-19 vaccine production